{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:33:01Z","timestamp":1787725981651,"version":"build-2784847793"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["INST 335\/454-1"],"award-info":[{"award-number":["INST 335\/454-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1038\/s41380-021-01385-7","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T02:02:33Z","timestamp":1636941753000},"page":"840-848","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Discovery of a novel pseudo \u03b2-hairpin structure of N-truncated amyloid-\u03b2 for use as a vaccine against Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8062-8302","authenticated-orcid":false,"given":"Preeti","family":"Bakrania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Bouter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Bouter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9126-3356","authenticated-orcid":false,"given":"Nicola","family":"Beindorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemma","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chido","family":"Mpamhanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Love","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3939-0996","authenticated-orcid":false,"given":"Mark D.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8453-228X","authenticated-orcid":false,"given":"Thomas A.","family":"Bayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"key":"1385_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","volume":"46","author":"CA McLean","year":"1999","unstructured":"McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, et al. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease. Ann Neurol. 1999;46:860\u20136.","journal-title":"Ann Neurol"},{"key":"1385_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, et al. Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med. 2008;14:837\u201342.","journal-title":"Nat Med"},{"key":"1385_CR3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002;416:535\u20139.","journal-title":"Nature"},{"key":"1385_CR4","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","volume":"27","author":"GM Shankar","year":"2007","unstructured":"Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL. Natural Oligomers of the Alzheimer Amyloid-{beta} protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci.2007;27:2866\u201375.","journal-title":"J Neurosci"},{"key":"1385_CR5","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00401-014-1287-x","volume":"127","author":"TA Bayer","year":"2014","unstructured":"Bayer TA, Wirths O. Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer\u2019s disease. Acta Neuropathol. 2014;127:787\u2013801.","journal-title":"Acta Neuropathol"},{"key":"1385_CR6","doi-asserted-by":"publisher","first-page":"15419","DOI":"10.1074\/jbc.R118.003999","volume":"293","author":"J Dunys","year":"2018","unstructured":"Dunys J, Valverde A, Checler F. Are N- and C-terminally truncated Abeta species key pathological triggers in Alzheimer\u2019s disease? J Biol Chem.2018;293:15419\u201328.","journal-title":"J Biol Chem"},{"key":"1385_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00401-010-0690-1","volume":"120","author":"E Portelius","year":"2010","unstructured":"Portelius E, Bogdanovic N, Gustavsson MK, Volkmann I, Brinkmalm G, Zetterberg H, et al. Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer\u2019s disease. Acta Neuropathol. 2010;120:185\u201393.","journal-title":"Acta Neuropathol"},{"key":"1385_CR8","doi-asserted-by":"publisher","first-page":"962","DOI":"10.15252\/embr.201643519","volume":"18","author":"KM Grochowska","year":"2017","unstructured":"Grochowska KM, Yuanxiang P, Bar J, Raman R, Brugal G, Sahu G, et al. Posttranslational modification impact on the mechanism by which amyloid-beta induces synaptic dysfunction. EMBO Rep. 2017;18:962\u201381.","journal-title":"EMBO Rep"},{"key":"1385_CR9","doi-asserted-by":"publisher","first-page":"38825","DOI":"10.1074\/jbc.R111.288308","volume":"286","author":"S Jawhar","year":"2011","unstructured":"Jawhar S, Wirths O, Bayer TA. Pyroglutamate Abeta - a hatchet man in Alzheimer disease. J Biol Chem.2011;286:38825\u201332.","journal-title":"J Biol Chem"},{"key":"1385_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/srep17338","volume":"5","author":"G Antonios","year":"2015","unstructured":"Antonios G, Borgers H, Richard BC, Brauss A, Meissner J, Weggen S, et al. Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X. Sci Rep. 2015;5:17338.","journal-title":"Sci Rep"},{"key":"1385_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat Rev Mol Cell Biol. 2007;8:101\u201312.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1385_CR12","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","volume":"101","author":"DM Walsh","year":"2007","unstructured":"Walsh DM, Selkoe DJ. Abeta oligomers - a decade of discovery. J Neurochem.2007;101:1172\u201384.","journal-title":"J Neurochem"},{"key":"1385_CR13","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/jnr.10328","volume":"69","author":"MD Kirkitadze","year":"2002","unstructured":"Kirkitadze MD, Bitan G, Teplow DB. Paradigm shifts in Alzheimer\u2019s disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. J Neurosci Res.2002;69:567\u201377.","journal-title":"J Neurosci Res"},{"key":"1385_CR14","doi-asserted-by":"publisher","first-page":"14745","DOI":"10.1073\/pnas.0905127106","volume":"106","author":"K Ono","year":"2009","unstructured":"Ono K, Condron MM, Teplow DB. Structure\u2013neurotoxicity relationships of amyloid \u03b2-protein oligomers. Proc Natl Acad Sci. 2009;106:14745\u201350.","journal-title":"Proc Natl Acad Sci"},{"key":"1385_CR15","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/nsmb1345","volume":"14","author":"S Chimon","year":"2007","unstructured":"Chimon S, Shaibat MA, Jones CR, Calero DC, Aizezi B, Ishii Y. Evidence of fibril-like beta-sheet structures in a neurotoxic amyloid intermediate of Alzheimer\u2019s beta-amyloid. Nat Struct Mol Biol. 2007;14:1157\u201364.","journal-title":"Nat Struct Mol Biol"},{"key":"1385_CR16","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003;300:486\u20139.","journal-title":"Science"},{"key":"1385_CR17","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci.2006;26:10129\u201340.","journal-title":"J Neurosci"},{"key":"1385_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00401-013-1129-2","volume":"126","author":"Y Bouter","year":"2013","unstructured":"Bouter Y, Dietrich K, Wittnam JL, Rezaei-Ghaleh N, Pillot T, Papot-Couturier S, et al. N-truncated amyloid beta (Abeta) 4-42 forms stable aggregates and induces acute and long-lasting behavioral deficits. Acta Neuropathol. 2013;126:189\u2013205.","journal-title":"Acta Neuropathol"},{"key":"1385_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch W. Xds. Acta Crystallogr D Biol Crystallogr. 2010;66:125\u201332.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"1385_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"67","author":"MD Winn","year":"2011","unstructured":"Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, et al. Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr. 2011;67:235\u201342.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"1385_CR21","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1107\/S0907444905001617","volume":"61","author":"AJ McCoy","year":"2005","unstructured":"McCoy AJ, Grosse-Kunstleve RW, Storoni LC, Read RJ. Likelihood-enhanced fast translation functions. Acta Crystallogr D Biol Crystallogr. 2005;61:458\u201364.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"1385_CR22","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46:W296\u2013303.","journal-title":"Nucleic Acids Res"},{"key":"1385_CR23","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004;60:2126\u201332.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"1385_CR24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1107\/S0907444996012255","volume":"53","author":"GN Murshudov","year":"1997","unstructured":"Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr. 1997;53:240\u201355.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"1385_CR25","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner D, Afonine PV, Baker ML, Bunkoczi G, Chen VB, Croll TI, et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr D Struct Biol. 2019;75:861\u201377.","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"1385_CR26","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1107\/S0021889809008784","volume":"42","author":"RP Joosten","year":"2009","unstructured":"Joosten RP, Salzemann J, Bloch V, Stockinger H, Berglund AC, Blanchet C, et al. PDB_REDO: automated re-refinement of X-ray structure models in the PDB. J Appl Crystallogr.2009;42:376\u201384.","journal-title":"J Appl Crystallogr"},{"key":"1385_CR27","doi-asserted-by":"publisher","first-page":"8154","DOI":"10.1074\/jbc.M111.308601","volume":"287","author":"JL Wittnam","year":"2012","unstructured":"Wittnam JL, Portelius E, Zetterberg H, Gustavsson MK, Schilling S, Koch B, et al. Pyroglutamate amyloid \u03b2 (A\u03b2) aggravates behavioral deficits in transgenic amyloid mouse model for Alzheimer disease. J Biol Chem.2012;287:8154\u201362.","journal-title":"J Biol Chem"},{"key":"1385_CR28","doi-asserted-by":"publisher","first-page":"196.e129","DOI":"10.1016\/j.neurobiolaging.2010.05.027","volume":"33","author":"S Jawhar","year":"2012","unstructured":"Jawhar S, Trawicka A, Jenneckens C, Bayer TA, Wirths O. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2012;33:196.e129\u201340.","journal-title":"Neurobiol Aging"},{"key":"1385_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00702-009-0314-x","volume":"117","author":"O Wirths","year":"2010","unstructured":"Wirths O, Bethge T, Marcello A, Harmeier A, Jawhar S, Lucassen PJ, et al. Pyroglutamate Abeta pathology in APP\/PS1KI mice, sporadic and familial Alzheimer\u2019s disease cases. J Neural Transm (Vienna). 2010;117:85\u201396.","journal-title":"J Neural Transm (Vienna)"},{"key":"1385_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","volume":"11","author":"R Morris","year":"1984","unstructured":"Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods.1984;11:47\u201360.","journal-title":"J Neurosci Methods"},{"key":"1385_CR31","doi-asserted-by":"crossref","unstructured":"Bouter C, Henniges P, Franke TN, Irwin C, Sahlmann CO, Sichler ME, et al. F-FDG-PET detects drastic changes in brain metabolism in the Tg4-42 model of Alzheimer\u2019s Disease. Front Aging Neurosci. 2018;10:425.","DOI":"10.3389\/fnagi.2018.00425"},{"key":"1385_CR32","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2967\/jnumed.112.114660","volume":"54","author":"A Rominger","year":"2013","unstructured":"Rominger A, Brendel M, Burgold S, Keppler K, Baumann K, Xiong G, et al. Longitudinal assessment of cerebral beta-amyloid deposition in mice overexpressing Swedish mutant beta-amyloid precursor protein using 18F-florbetaben PET. J Nucl Med.2013;54:1127\u201334.","journal-title":"J Nucl Med"},{"key":"1385_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fmed.2019.00071","volume":"6","author":"C Bouter","year":"2019","unstructured":"Bouter C, Bouter Y. (18)F-FDG-PET in Mouse Models of Alzheimer\u2019s Disease. Front Med (Lausanne). 2019;6:71.","journal-title":"Front Med (Lausanne)"},{"key":"1385_CR34","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","volume":"19","author":"G Chetelat","year":"2020","unstructured":"Chetelat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, et al. Amyloid-PET and (18)F-FDG-PET in the diagnostic investigation of Alzheimer\u2019s disease and other dementias. Lancet Neurol. 2020;19:951\u201362.","journal-title":"Lancet Neurol"},{"key":"1385_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/2051-5960-1-56","volume":"1","author":"G Antonios","year":"2013","unstructured":"Antonios G, Saiepour N, Bouter Y, Richard BC, Paetau A, Verkkoniemi-Ahola A, et al. N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody. Acta Neuropathol Commun. 2013;1:56.","journal-title":"Acta Neuropathol Commun"},{"key":"1385_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/22124","volume":"400","author":"D Schenk","year":"1999","unstructured":"Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 1999;400:173\u20137.","journal-title":"Nature"},{"key":"1385_CR37","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1212\/01.WNL.0000148604.77591.67","volume":"64","author":"AJ Bayer","year":"2005","unstructured":"Bayer AJ, Bullock R, Jones RW, Wilkinson D, Paterson KR, Jenkins L, et al. Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD. Neurology. 2005;64:94\u2013101.","journal-title":"Neurology"},{"key":"1385_CR38","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","volume":"64","author":"S Gilman","year":"2005","unstructured":"Gilman S, Koller M, Black RS, Jenkins L, Griffith SG, Fox NC, et al. Clinical effects of A{beta} immunization (AN1792) in patients with AD in an interrupted trial. Neurology. 2005;64:1553\u201362.","journal-title":"Neurology"},{"key":"1385_CR39","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","volume":"372","author":"C Holmes","year":"2008","unstructured":"Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, et al. Long-term effects of A\u03b242 immunisation in Alzheimer\u2019s disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet. 2008;372:216\u201323.","journal-title":"Lancet"},{"key":"1385_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1749-6632.1993.tb23037.x","volume":"695","author":"C Haass","year":"1993","unstructured":"Haass C, Hung AY, Schlossmacher MG, Oltersdorf T, Teplow DB, Selkoe DJ. Normal cellular processing of the beta-amyloid precursor protein results in the secretion of the amyloid beta peptide and related molecules. Ann N. Y Acad Sci. 1993;695:109\u201316.","journal-title":"Ann N. Y Acad Sci"},{"key":"1385_CR41","doi-asserted-by":"publisher","first-page":"9677","DOI":"10.1523\/JNEUROSCI.4742-11.2012","volume":"32","author":"O Adolfsson","year":"2012","unstructured":"Adolfsson O, Pihlgren M, Toni N, Varisco Y, Buccarello AL, Antoniello K, et al. An effector-reduced anti-beta-amyloid (Abeta) antibody with unique abeta binding properties promotes neuroprotection and glial engulfment of Abeta. J Neurosci.2012;32:9677\u201389.","journal-title":"J Neurosci"},{"key":"1385_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/srep39374","volume":"6","author":"M Ultsch","year":"2016","unstructured":"Ultsch M, Li B, Maurer T, Mathieu M, Adolfsson O, Muhs A, et al. Structure of crenezumab complex with abeta shows loss of beta-hairpin. Sci Rep. 2016;6:39374.","journal-title":"Sci Rep"},{"key":"1385_CR43","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1212\/WNL.0b013e3181c67808","volume":"73","author":"S Salloway","year":"2009","unstructured":"Salloway S, Sperling R, Gilman S, Fox NC, Blennow K, Raskind M, et al. A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology. 2009;73:2061\u201370.","journal-title":"Neurology"},{"key":"1385_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/srep01302","volume":"3","author":"LA Miles","year":"2013","unstructured":"Miles LA, Crespi GA, Doughty L, Parker MW. Bapineuzumab captures the N-terminus of the Alzheimer\u2019s disease amyloid-beta peptide in a helical conformation. Sci Rep. 2013;3:1302.","journal-title":"Sci Rep"},{"key":"1385_CR45","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nn842","volume":"5","author":"JC Dodart","year":"2002","unstructured":"Dodart JC, Bales KR, Gannon KS, Greene SJ, DeMattos RB, Mathis C, et al. Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer\u2019s disease model. Nat Neurosci. 2002;5:452\u20137.","journal-title":"Nat Neurosci"},{"key":"1385_CR46","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00401-015-1489-x","volume":"130","author":"Y Bouter","year":"2015","unstructured":"Bouter Y, Lopez Noguerola JS, Tucholla P, Crespi GA, Parker MW, Wiltfang J, et al. Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncated Abeta in sporadic Alzheimer disease cases and mouse models. Acta Neuropathol. 2015;130:713\u201329.","journal-title":"Acta Neuropathol"},{"key":"1385_CR47","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3233\/JAD-140741","volume":"43","author":"S Tucker","year":"2015","unstructured":"Tucker S, Moller C, Tegerstedt K, Lord A, Laudon H, Sjodahl J, et al. The murine version of BAN2401 (mAb158) selectively reduces amyloid-beta protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice. J Alzheimers Dis.2015;43:575\u201388.","journal-title":"J Alzheimers Dis"},{"key":"1385_CR48","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.neuron.2012.10.029","volume":"76","author":"RB Demattos","year":"2012","unstructured":"Demattos RB, Lu J, Tang Y, Racke MM, Delong CA, Tzaferis JA, et al. A plaque-specific antibody clears existing beta-amyloid plaques in Alzheimer\u2019s disease mice. Neuron. 2012;76:908\u201320.","journal-title":"Neuron"},{"key":"1385_CR49","doi-asserted-by":"publisher","first-page":"12713","DOI":"10.1074\/jbc.M117.777839","volume":"292","author":"A Piechotta","year":"2017","unstructured":"Piechotta A, Parthier C, Kleinschmidt M, Gnoth K, Pillot T, Lues I, et al. Structural and functional analyses of pyroglutamate-amyloid-beta-specific antibodies as a basis for Alzheimer immunotherapy. J Biol Chem.2017;292:12713\u201324.","journal-title":"J Biol Chem"},{"key":"1385_CR50","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharm Sci. 1991;12:383\u20138.","journal-title":"Trends Pharm Sci"},{"key":"1385_CR51","doi-asserted-by":"publisher","first-page":"n156","DOI":"10.1136\/bmj.n156","volume":"372","author":"SF Ackley","year":"2021","unstructured":"Ackley SF, Zimmerman SC, Brenowitz WD, Tchetgen Tchetgen EJ, Gold AL, Manly JJ, et al. Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis. BMJ. 2021;372:n156.","journal-title":"BMJ"},{"key":"1385_CR52","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun MA, Lo AC, Duggan Evans C, Wessels AM, Ardayfio PA, Andersen SW, et al. Donanemab in early Alzheimer\u2019s Disease. N. Engl J Med.2021;384:1691\u2013704.","journal-title":"N. Engl J Med"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-021-01385-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-021-01385-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-021-01385-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T10:35:51Z","timestamp":1744194951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-021-01385-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1385"],"URL":"https:\/\/doi.org\/10.1038\/s41380-021-01385-7","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]},"assertion":[{"value":"14 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LifeArc and University Medicine Goettingen hold patents on the project.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}